微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-20-100936 Act: 34 Size: 46 KB 网页链接
$Myomo(MYO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-20-079236 Act: 33 Size: 49 KB 网页链接
$Myomo(MYO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-010809 Act: 34 Size: 9 MB 网页链接
$Myomo(MYO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-024252 Act: 34 Size: 93 KB 网页链接
$Myomo(MYO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-20-004550 Act: 34 Size: 86 KB 网页链接
$Myomo(MYO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-023197 Act: 34 Size: 105 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-010100 Size: 7 KB 网页链接
$Myomo(MYO)$ 内部交易: 2020-02-13,CFO,HENRY DAVID A ,买入,3500普通股, $6.99
$Myomo(MYO)$ 内部交易: 2020-02-13,CEO,GUDONIS PAUL R ,买入,6000普通股, $6.99
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-009700 Size: 10 KB 网页链接